Vantive to Invest $100 Million in Mountain Home, Arkansas Dialysis Products Plant

Vantive, a vital organ therapy company with a 70-year legacy of kidney care innovation, is investing $100 million to expand its operations in Mountain Home, Arkansas. The company plans to create up to 175 new jobs over the next four years, starting with 75 in the first year.

New tubing line, sterilizers and lab

The investment will fund a range of capital expenditures at the Mountain Home site, including a new tubing line, new sterilizers, new compressors, a new chemistry lab and other expansion projects. The facility is a key manufacturing site for essential components of home dialysis therapies and currently has approximately 800 employees. The project builds on $100 million in past investments completed in 2025.

Chris Toth, CEO of Vantive said:

“As demand for our therapies continues to grow, this expansion will increase our capacity, create new jobs, and help ensure that patients worldwide have access to the home dialysis products they rely on.”

Arkansas Governor Sarah Huckabee Sanders said:

“This investment is a leap forward in Vantive’s commitment to advancing kidney care while simultaneously expanding opportunity for Arkansans and strengthening Mountain Home’s workforce and economy for years to come.”